HuagongsheHuagongshe Chemistry Print Report · For research reference only
945400-88-4 → Tert-butyl (5-{6-[(tert-butoxycarbonyl)amino]-1,3-benzothiazol-2-yl}pyridin-2-yl)methylcarbamate
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 945400-88-4 | HCID 57553402 | — |
| Reactant | tert-Butyl [5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)pyridin-2-yl]methylcarbamate | HCID 86626541 | — |
| Reactant | Tert-butyl[5-(6-carbamoyl-1,3-benzothiazol-2-yl)pyridin-2-yl]methylcarbamate | HCID 86626543 | — |
| Product | Tert-butyl (5-{6-[(tert-butoxycarbonyl)amino]-1,3-benzothiazol-2-yl}pyridin-2-yl)methylcarbamate | HCID 86626544 | 80.3% |
Reaction Steps
tert-Butyl (2-bromo-1,3-benzothiazol-6-yl)carbamate (100 mg, 0.30 mmol) and tert-butyl [5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)pyridin-2-yl]methylcarbamate (0.146 g, 0.46 mmol) were subjected to the procedure used for the preparation of tert-butyl[5-(6-carbamoyl-1,3-benzothiazol-2-yl)pyridin-2-yl]methylcarbamate. This gave the product (110 mg) as a white solid. MS m/z (M−H) 455.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08163928B2 |
| Source dataset | uspto-grants-2012_04 |
| ORD ID | ord-f3fcbabf844a45c8b20b78d872a17c67 |
| Source note | uspto-grants-2012_04 |